Literature DB >> 33728228

Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants.

Ricardo A Zimerman1, Flavio A Cadegiani2,3, Rute Alves Pereira E Costa4, Andy Goren5, Bruno Campello de Souza6.   

Abstract

Background While public health strategies to contain the current coronavirus disease 2019 (COVID-19) pandemic are primarily focused on social distancing and isolation, emerging evidence suggest that in some regions social isolation failed to lead to further decrease in the number of COVID-19 deaths in the long run. This apparent paradox was particularly observed in the northern region of Brazil, in the state of Amazonas. We hypothesized that the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations, leading to more transmissible and pathogenic variants, could explain the lack of further reductions in COVID-19 new cases and related deaths in some regions. Our objective is to determine if social isolation is associated with the emergence of new SARS-CoV-2 variants, particularly the P.1 lineage and E484K mutants, in Brazil and in the state of Amazonas. Materials and methods We assessed the prevailing SARS-CoV-2 genomes present in Brazil available on the GISAID (Global Initiative on Sharing All Influenza Data) database collected between June 1, 2020, and January 31, 2021. Data regarding demographics, lineage, and prevalence of P.1 lineage and E484K mutations were obtained. Social isolation was measured using the Social Isolation Index (SII), which quantifies the percentage of individuals that stayed within a distance of 450 meters from their homes on a given day, between February 1, 2020, and January 24, 2021. The number of daily COVID-19 deaths was obtained from the Brazilian Ministry of Health (OpenDataSUS, 2021) between March 12, 2020, and January 10, 2021. SII was correlated with the prevalence P.1 lineage and E484K mutations in the eight following weeks. All univariate associations were estimated using the Spearman Correlation Index. 3D surfaces were employed to reflect the relationship between time, social isolation, and prevalence of genomic variants simultaneously. Results A total of 773 and 77 samples were obtained in Brazil and in the Amazonas state, respectively. In the state of Amazonas, SII on a given week was positively, significantly, and moderately or strongly (r > 0.6) correlated with the prevalence of both P.1 lineage and other E484K variants in the six following weeks after the SII on a given week. Conversely, in overall Brazil, correlations between SII and P.1 lineage and E484K variants were weaker and shorter, or negative, respectively. When SII was below 40%, P.1 lineage or E484K variants were not detected in the following weeks. When SII was above 40%, apparently exponential positive correlations between SII and prevalence of both P.1 lineage and E484K variants were observed. Conclusion The results of this study indicate that SII above 40% is associated with the emergence of SARS-CoV-2 E484K variants and P.1 lineage in the state of Amazonas, which was not observed in overall Brazil.
Copyright © 2021, Zimerman et al.

Entities:  

Keywords:  covid-19; e484k mutation; pandemic; sars-cov-2; sars-cov-2 variants

Year:  2021        PMID: 33728228      PMCID: PMC7949745          DOI: 10.7759/cureus.13819

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  4 in total

1.  Strategies for containing an emerging influenza pandemic in Southeast Asia.

Authors:  Neil M Ferguson; Derek A T Cummings; Simon Cauchemez; Christophe Fraser; Steven Riley; Aronrag Meeyai; Sopon Iamsirithaworn; Donald S Burke
Journal:  Nature       Date:  2005-08-03       Impact factor: 49.962

2.  Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China.

Authors:  Akira Endo; Sam Abbott; Adam J Kucharski; Sebastian Funk
Journal:  Wellcome Open Res       Date:  2020-07-10

3.  Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.

Authors:  Ester C Sabino; Lewis F Buss; Maria P S Carvalho; Carlos A Prete; Myuki A E Crispim; Nelson A Fraiji; Rafael H M Pereira; Kris V Parag; Pedro da Silva Peixoto; Moritz U G Kraemer; Marcio K Oikawa; Tassila Salomon; Zulma M Cucunuba; Márcia C Castro; Andreza Aruska de Souza Santos; Vítor H Nascimento; Henrique S Pereira; Neil M Ferguson; Oliver G Pybus; Adam Kucharski; Michael P Busch; Christopher Dye; Nuno R Faria
Journal:  Lancet       Date:  2021-01-27       Impact factor: 79.321

4.  NS4/5 mutations enhance flavivirus Bamaga virus infectivity and pathogenicity in vitro and in vivo.

Authors:  Agathe M G Colmant; Helle Bielefeldt-Ohmann; Laura J Vet; Caitlin A O'Brien; Richard A Bowen; Airn E Hartwig; Steven Davis; Thisun B H Piyasena; Gervais Habarugira; Jessica J Harrison; Jody Hobson-Peters; Roy A Hall
Journal:  PLoS Negl Trop Dis       Date:  2020-03-23
  4 in total
  2 in total

1.  Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review.

Authors:  Mari Somerville; Janet A Curran; Justine Dol; Leah Boulos; Lynora Saxinger; Alexander Doroshenko; Stephanie Hastings; Bearach Reynolds; Allyson J Gallant; Hwayeon Danielle Shin; Helen Wong; Daniel Crowther; Marilyn Macdonald; Ruth Martin-Misener; Jeannette Comeau; Holly McCulloch; Andrea C Tricco
Journal:  BMJ Open       Date:  2021-12-02       Impact factor: 3.006

Review 2.  Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive Review.

Authors:  Reinaldo B Bestetti; Rosemary Furlan-Daniel; Vinicius M R Silva
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.